Literature DB >> 17199160

Intravitreal Bioerudivel sustained-release triamcinolone microspheres system (RETAAC). Preliminary report of its potential usefulnes for the treatment of diabetic macular edema.

J A Cardillo, A A Souza-Filho, A G Oliveira.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17199160

Source DB:  PubMed          Journal:  Arch Soc Esp Oftalmol        ISSN： 0365-6691


× No keyword cloud information.
  14 in total

Review 1.  Challenges and opportunities for drug delivery to the posterior of the eye.

Authors:  Fernando J Cabrera; Daniel C Wang; Kartik Reddy; Ghanashyam Acharya; Crystal S Shin
Journal:  Drug Discov Today       Date:  2019-06-05       Impact factor: 7.851

Review 2.  Effectiveness of the Dexamethasone Intravitreal Implant for Treatment of Patients with Diabetic Macular Oedema.

Authors:  Marco Dutra Medeiros; Micol Alkabes; Paolo Nucci
Journal:  Eur Endocrinol       Date:  2014-08-28

Review 3.  Pharmaceutical microscale and nanoscale approaches for efficient treatment of ocular diseases.

Authors:  I Bravo-Osuna; V Andrés-Guerrero; P Pastoriza Abal; I T Molina-Martínez; R Herrero-Vanrell
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

4.  New Drugs and New Posterior Delivery Methods in CME.

Authors:  João Rafael de Oliveira Dias; Renata Portella Nunes; Raquel Goldhardt
Journal:  Curr Ophthalmol Rep       Date:  2017-04-07

Review 5.  Intraocular sustained-release delivery systems for triamcinolone acetonide.

Authors:  Saffar Mansoor; Baruch D Kuppermann; M Cristina Kenney
Journal:  Pharm Res       Date:  2009-01-28       Impact factor: 4.200

6.  Evaluations of therapeutic efficacy of intravitreal injected polylactic-glycolic acid microspheres loaded with triamcinolone acetonide on a rabbit model of uveitis.

Authors:  Wenchang Li; Bing He; Wenbing Dai; Qiang Zhang; Yuling Liu
Journal:  Int Ophthalmol       Date:  2013-07-19       Impact factor: 2.031

Review 7.  Biodegradable intraocular therapies for retinal disorders: progress to date.

Authors:  Noriyuki Kuno; Shinobu Fujii
Journal:  Drugs Aging       Date:  2010-02-01       Impact factor: 3.923

8.  Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema.

Authors:  Rocío Herrero-Vanrell; Jose Augusto Cardillo; Baruch D Kuppermann
Journal:  Clin Ophthalmol       Date:  2011-02-01

Review 9.  Drug delivery implants in the treatment of vitreous inflammation.

Authors:  Jillian Wang; Angela Jiang; Malav Joshi; John Christoforidis
Journal:  Mediators Inflamm       Date:  2013-09-28       Impact factor: 4.711

10.  Characterization of liposomal carriers for the trans-scleral transport of Ranibizumab.

Authors:  Rini Rachel Joseph; Dulcia Wei Ni Tan; Moreno Raja Miguel Ramon; Jayaganesh V Natarajan; Rupesh Agrawal; Tina T Wong; Subbu S Venkatraman
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.